RobertoTZoriMD

Medical Genetics • Gainesville, FL

Clinical Cytogenetics, Clinical Genetics

Professor, Pediatrics, University of Florida College of Medicine

Join to view full profile

Dr. Zori is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zori's full profile

Already have an account?

Office
1600 Sw Archer Rd
Gainesville, FL 32610
Phone+1 352-392-4104

Fax+1 352-392-3051

Summary

Professor and chief clinical genetics and metabolism Gainesville Florida department of peds university of florida

Education & Training

University of FloridaResidency, Pediatrics, 1988 - 1990
UMass Chan - BaystateResidency, Pediatrics, 1980 - 1983
Odessa Medical UniversityClass of 1979

Certifications & Licensure

FL State Medical License 1988 - 2026
American Board of Medical Genetics and Genomics Clinical Genetics
American Board of Pediatrics Pediatrics
American Board of Medical Genetics and Genomics Clinical Cytogenetics and Genomics

Clinical Trials

An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165 Start of enrollment: 2013 May 01
Completed
Phase 3
A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders Start of enrollment: 2014 Dec 31
Completed
Phase 4
A Study of AEB1102 (Pegzilarginase) in Patients With Arginase I Deficiency Start of enrollment: 2017 Dec 07
Completed
Phase 2
Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs) Start of enrollment: 2018 Feb 20
Completed
Phase 4
Roles: Contact, Principal Investigator
First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria Start of enrollment: 2022 Oct 31
Recruiting
Phase 1
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial program.
Cary O Harding, Nicola Longo, Hope Northrup, Stephanie Sacharow, Rani Singh
Molecular Genetics and Metabolism Reports. 2024-06-01
4 citations
Long-term comparative effectiveness of pegvaliase versus medical nutrition therapy with and without sapropterin in adults with phenylketonuria.
Barbara K Burton, Gillian E Clague, Cary O Harding, Ece Kucuksayrac, Drew G Levy
Molecular Genetics and Metabolism. 2024-01-01
10 citations
Efficacy and safety of a synthetic biotic for treatment of phenylketonuria: a phase 2 clinical trial.
Jerry Vockley, Neal Sondheimer, Marja Puurunen, George A Diaz, Ilona Ginevic
Nature Metabolism. 2023-10-01